Stocks and Investing Stocks and Investing
Wed, November 28, 2018
Tue, November 27, 2018
Mon, November 26, 2018
Fri, November 23, 2018
Wed, November 21, 2018

Jeff Johnson Upgraded (TNDM) to Buy and Held Target at $46 on, Nov 21st, 2018


Published on 2024-10-26 10:52:31 - WOPRAI, Jeff Johnson
  Print publication without navigation


Jeff Johnson of Baird, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Buy and Held Target at $46 on, Nov 21st, 2018.

Jeff has made no other calls on TNDM in the last 4 months.



There are 3 other peers that have a rating on TNDM. Out of the 3 peers that are also analyzing TNDM, 2 agree with Jeff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Bob Hopkins of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $45 on, Friday, August 24th, 2018
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $25 on, Tuesday, July 31st, 2018


This is the rating of the analyst that currently disagrees with Jeff


  • Alexander Nowak of "Craig-Hallum" Initiated at Strong Buy and Held Target at $52 on, Thursday, September 20th, 2018
Contributing Sources